Dec 6 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Amgen, Equitable Holdings and Royal
Caribbean on Tuesday.
HIGHLIGHTS
* Amgen Inc AMGN.O : Oppenheimer raises target price to $310 from $300
* Equitable Holdings Inc EQH.N : RBC cuts to sector perform from outperform
* Reinsurance Group of America Inc RGA.N : RBC raises to outperform from sector perform
* Royal Caribbean Group RCL.N : JP Morgan assumes with underweight vs overweight; PT $47 vs
$106
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.
* AAR Corp AIR.N : Melius Research initiates coverage with buy rating and $69 PT
* Amgen Inc AMGN.O : Oppenheimer raises target price to $310 from $300
* Bed Bath & Beyond Inc BBBY.O : Jefferies cuts target price to $3.5 from $7
* Cerevel Therapeutics Holdings Inc CERE.O : JP Morgan cuts PT to $40 from $49
* Driven Brands Holdings Inc DRVN.O : RBC initiates coverage with outperform rating; PT $37
* Equitable Holdings Inc EQH.N : RBC cuts to sector perform from outperform
* Equitable Holdings Inc EQH.N : RBC cuts target price to $33 from $34
* Fidelity National Financial Inc FNF.N : Credit Suisse cuts target price to $47 from $48
* Flowers Foods Inc FLO.N : Jefferies raises target price to $28 from $27
* Genasys Inc GNSS.O : Ascendiant Capital Markets cuts target price to $7 from $8
* Intellia Therapeutics Inc NTLA.O : Credit Suisse cuts target price to $88 from $109
* Legend Biotech Corp LEGN.O : JP Morgan raises target price to $65 from $61
* Norwegian Cruise Line Holdings NCLH.N : JP Morgan assumes with overweight rating; PT $30 vs
$35
* R1 RCM Holdco Inc RCM.O : RBC raises target price to $14 from $12
* Reinsurance Group of America Inc RGA.N : RBC raises to outperform from sector perform
* Reinsurance Group of America Inc RGA.N : RBC raises target price to $170 from $145
* Royal Caribbean Group RCL.N : JP Morgan assumes with underweight vs overweight; PT $47 vs
$106
* Sage Therapeutics Inc SAGE.O : JP Morgan cuts target price to $60 from $92
* SL Green Realty Corp SLG.N : Scotiabank cuts to sector underperform from sector perform
* SL Green Realty Corp SLG.N : Scotiabank cuts target price to $34 from $43
* Spirit Realty Capital Inc SRC.N : JP Morgan cuts target price to $49 from $52
* Veracyte Inc VCYT.O : Stephens raises target price to $32 from $30
* Veru Inc VERU.O : Jefferies cuts target price to $3 from $10
* VF Corp VFC.N : Cowen and Company cuts target price to $27 from $29
* VF Corp VFC.N : JP Morgan cuts target price to $23 from $27
* Williams-Sonoma Inc WSM.N : Jefferies cuts target price to $98 from $100
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))